Abstract: Three non-isoprenoid botryane sesquiterpenoids, named boledulins A-C (1-3), have been isolated from the cultures of basidiomycete Boletus edulis Bull. The structures were established by means of spectroscopic methods. Boledulin A (1) exhibited moderate inhibitory activity against five human cancer cell lines.
Introduction
Botryane sesquiterpenoids possess a non-isopreniod system skeleton, which have been found limited to several fungi such as Botrytis cinerea 1 and Daldinia concentrica 2 . The representative botryane sesquiterpenoids are botrydial 1a and its derivatives, which are characterized from phytopathogenic fungus B. cinerea. These sesquiterpenoids showed a wide range of biological activities. For instance, they were responsible for the typical lesions associated with B. cinerea infection, and they played an important role in the pathogenicity of the organism in vivo. 1c,3 Botryane sesquiterpenoids attracted great interests of chemists to carry out a large number of investigations including chemical transformations, 3b structure-activity relationships, 1c synthesis, 4 and biosynthesis 5 . Our group has long been focused on the chemical study on higher fungi. Recently, three new botryane sesquiterpeniods, boledulins A-C (1-3), have been isolated from cultures of Boletus edulis Bull, an edible basidiomycete collected from southwest of China. The structures were established by extensive spectroscopic data. It is noted that compound 3 is a 15-nor-botryane sesquiterpenoid which was seldom found previously. In addition, compounds 1-3 were evaluated for their cytotoxicity against five human cancer cell lines. This paper reports the isolation, structural elucidation, and cytotoxicity of these compounds. In the HMBC spectrum, the correlation of a methoxy signal at δ H 3.70 (3H, s) with δ C 174.6 (s, C-10) established a methyl ester group. A key correlation of δ H 2.45 (1H, d, J = 12 Hz, H-1) with C-10 suggested the linkage of C-10 to the methine. Starting from this methine, a structural fragment was established by the analysis of 1 H-1 H COSY spectrum as shown in Figure 1 . The HMBC correlations of H-1 and δ H 1.56 (1H, d, J = 11.0 Hz, H-5) with the oxygen-containing quaternary carbon signal at δ C 87.8 (s, C-9) revealed the connections of C-9 to C-1 and C-5, respectively. Hence, ring A was established as shown in Figure 1 . Ring B was readily built due to the rest of carbon and proton resonances leading to the only perfect linkage, which was supported further by the HMBC correlations ( Figure 1 ). In addition, a methoxy group placed at *To whom correspondence should be addressed. E-mail: jkliu@mail.kib.ac.cn. C-15 was also deduced from the HMBC correlation (Figure 1 ).
Results and Discussion
In the ROESY spectrum, the observed cross peaks of H-1/H-5, H-2/H-4, H-1/CH 3 -11, H-4/CH 3 -12 and H-4/CH 3 -14 suggested H-1, H-5, and Me-11 in the same side, while H-2, H-4, Me-12, and Me-14 in the opposite side. Further, these above ROESY cross peaks limited OH-9 to be the same side with H-1. Structurally, compound 1 should be a derivative of botrydial ([α] 20 D + 34), 1a the first botryane sesquiterpenoid isolated from Botrytis cinerea, 1a whose absolute configuration has been identified on the basis of synthesis and biosynthesis [4] [5] [6] .
Accordingly, the absolute configuration of 1 could be determined as 1S, 2R, 4S, 5R, 8S, 9S. Therefore, the structure of 1 (boledulin A) was established. (Tables 1 and 2 ) suggested that the backbone of 2 was the same as that of 1. Differences between them were identified to be a new double bond (δ C 136.4 and 150.9) and the loss of a methoxy group at C-15 in 2. The HMBC correlations of δ H 0.93 (3H, s, Me-14) with δ C 136.9 (s, C-9) and δ H 1.16 and 1.34 (each 3H, s, Me-12 and Me-13, respectively) with δ C 150.9 (s, C-5) suggested the double bond placed between C-5 and C-9. The HMBC correlations between H-1, H-4 and C-5, C-9 were also observed. Detailed analysis of other 2D NMR data confirmed that the other parts of 2 were the same as those of 1. Therefore, the structure of 2 (boledulin B) was established.
Compound 3 was isolated as white solid. (Table 1 ). These data suggested that compound 3 might be a bicyclic nor-sesquiterpenoid. suggested the link of C-9 to C-1 and C-5, respectively. Hence, the structure of ring A was established. The HMBC correlation between C-8 and C-9, which was derived from the degradation of a carbon at C-8. Analysis of other 1D and 2D NMR data established ring B as depicted in Figure 1 . Therefore, compound 3 was established to be a 15-nor-botryane sesquiterpenoid and named as boledulin C.
All compounds were evaluated for their cytotoxicities against five human cancer cell lines using the MTT method as reported previously. 7 The result displayed that compound 1 showed moderate cytotoxicity against five human cancer cell lines using cisplatin as the positive control, while compounds 2-3 were inactive against all the tested cell lines with IC 50 values of more than 40 M (Table 3) .
Experimental Section
General Experimental Procedures. Optical rotations were measured with a Jasco P-1020 polarimeter. IR spectra were obtained on a Bruker FT-IR Tensor 27 spectrometer using KBr pellets. 1D and 2D NMR spectra were run on an AV-400 MHz or a Bruker avance III-600 MHz spectrometer with TMS as an internal standard. Chemical shifts () were expressed in ppm with reference to solvent signals. HREIMS were recorded on a Waters Auto Premier P776 spectrometer. HRESIMS were recorded on an API QSTAR Pulsar i spectrometer. Column chromatography (CC) was performed on silica gel (200-300 mesh, Qingdao Marine Chemical Ltd., Qingdao, People's Republic of China). An Agilent 1100 series instrument equipped with Agilent ZORBAX SB-C18 column (5 μm, 4.6 mm × 150 mm) was used for high-performance liquid chromatography (HPLC) analysis, and a semipreparative Agilent ZORBAX SB-C18 column (5 μm, 9.4 mm × 150 mm) was used for the sample preparation. Fractions were monitored by TLC (GF 254, Qingdao Haiyang Chemical Co., Ltd. Qingdao), and spots were visualized by 10% H 2 SO 4 in ethanol. Cytotoxicity Assay. Five human cancer cell lines, breast cancer MCF-7, hepatocellular carcinoma SMMC-7721, human myeloid leukemia HL-60, colon cancer SW480, and lung cancer A-549 cells, were used in the cytotoxic assay. All the cells were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37 C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates. 7 Briefly, 100 µL adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition with initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compound dissolved in DMSO at concentrations of 0.0625, 0.32, 1.6, 8, and 40 μmol in triplicates for 48 h, with cisplatin (Sigma, USA) and taxol (National Institute for the Control of Pharmaceutical and Biological Products, P. R. China) as positive controls. After compound treatment, cell viability was detected and a cell growth curve was graphed. IC 50 values were calculated by Reed and Muench's method. 8 
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